HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert L Modlin Selected Research

Lepromatous Leprosy

5/2020ER Stress Regulates Immunosuppressive Function of Myeloid Derived Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ.
1/2016S100A12 Is Part of the Antimicrobial Network against Mycobacterium leprae in Human Macrophages.
10/2015IL-27 Suppresses Antimicrobial Activity in Human Leprosy.
2/2010Integrated pathways for neutrophil recruitment and inflammation in leprosy.
3/2005The human CD1-restricted T cell repertoire is limited to cross-reactive antigens: implications for host responses against immunologically related pathogens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert L Modlin Research Topics

Disease

32Infections
01/2021 - 08/2003
27Leprosy (Hansen's Disease)
11/2019 - 03/2003
16Tuberculosis (Tuberculoses)
01/2019 - 08/2003
8Acne Vulgaris
01/2022 - 08/2002
7Communicable Diseases (Infectious Diseases)
05/2020 - 03/2004
5Lepromatous Leprosy
05/2020 - 03/2005
5Inflammation (Inflammations)
04/2020 - 03/2005
5Bites and Stings (Sting)
01/2019 - 11/2012
4Bacterial Infections (Bacterial Infection)
03/2013 - 01/2003
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 05/2005
3Tuberculoid Leprosy
05/2020 - 04/2007
3Neoplasms (Cancer)
01/2020 - 03/2013
3Melanoma (Melanoma, Malignant)
01/2020 - 12/2015
3Porcine Reproductive and Respiratory Syndrome (PRRS)
07/2017 - 03/2012
3Virus Diseases (Viral Diseases)
03/2013 - 11/2006
2Autoimmune Diseases (Autoimmune Disease)
09/2015 - 05/2009
2Metabolic Diseases (Metabolic Disease)
08/2008 - 11/2006
1Atopic Dermatitis (Atopic Eczema)
10/2021
1Demyelinating Diseases (Demyelinating Disease)
08/2017
1Colonic Neoplasms (Colon Cancer)
12/2015
1Skin Diseases (Skin Disease)
02/2015
1Leukemia
10/2012

Drug/Important Bio-Agent (IBA)

13Vitamin DFDA LinkGeneric
04/2020 - 03/2006
11Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2003
6CathelicidinsIBA
01/2022 - 03/2006
6AntigensIBA
01/2019 - 08/2003
5RNA (Ribonucleic Acid)IBA
01/2022 - 07/2017
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 11/2012
5CytokinesIBA
10/2018 - 08/2002
4Interleukin-10 (Interleukin 10)IBA
05/2020 - 12/2007
4Interferon Type IIBA
01/2019 - 12/2012
4Messenger RNA (mRNA)IBA
01/2019 - 03/2006
4LigandsIBA
10/2018 - 03/2003
4Toll-Like Receptors (Toll-Like Receptor)IBA
07/2017 - 01/2003
4Pattern Recognition ReceptorsIBA
03/2012 - 03/2007
3Interleukin-17 (Interleukin 17)IBA
01/2021 - 05/2010
3InterferonsIBA
10/2019 - 12/2012
325-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
10/2018 - 03/2007
3GlycolipidsIBA
08/2017 - 08/2003
3Antiviral Agents (Antivirals)IBA
07/2017 - 11/2006
3Pathogen-Associated Molecular Pattern MoleculesIBA
07/2017 - 01/2010
3Toll-Like Receptor 2IBA
03/2012 - 08/2002
3LipidsIBA
01/2012 - 03/2005
3Anti-Bacterial Agents (Antibiotics)IBA
04/2011 - 08/2005
2Antimicrobial PeptidesIBA
01/2022 - 03/2013
2Biomarkers (Surrogate Marker)IBA
01/2020 - 11/2019
2Interleukin-15 (Interleukin 15)IBA
11/2019 - 01/2018
2Vitamin A (Retinol)FDA LinkGeneric
01/2019 - 01/2007
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2019 - 03/2005
2Interleukin-12 (IL 12)IBA
01/2018 - 12/2007
2lipoarabinomannan (LAM)IBA
01/2016 - 09/2004
2Phosphotransferases (Kinase)IBA
12/2012 - 11/2012
2Peptides (Polypeptides)IBA
08/2005 - 03/2005
1RetinoidsIBA
01/2022
1Interleukin-1 (Interleukin 1)IBA
10/2021
1HLA-DR Antigens (HLA-DR)IBA
05/2020
1NivolumabIBA
01/2020
1pembrolizumabIBA
01/2020
1DNA receptor (receptor, DNA)IBA
01/2019
1C.I. Solvent Yellow 56 (DEAB)IBA
01/2019
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2019
1Transfer RNA (tRNA)IBA
01/2018
1Nitric Oxide Synthase (NO Synthase)IBA
08/2017
1Reactive Nitrogen SpeciesIBA
08/2017
1GuanosineIBA
07/2017
1Adenosine (Adenocard)FDA LinkGeneric
07/2017
1HydrolasesIBA
11/2016
1GlucocorticoidsIBA
01/2016
1Mitogen-Activated Protein KinasesIBA
01/2016
1S100A12 ProteinIBA
01/2016
1Adenosine Monophosphate (AMP)IBA
12/2015
1cyclic guanosine monophosphate-adenosine monophosphateIBA
12/2015
1Interleukin-27 (Interleukin 27)IBA
10/2015
1InterleukinsIBA
09/2015
1Phospholipases (Phospholipase)IBA
02/2015
1CD40 Ligand (CD40L)IBA
05/2013
1AlginatesIBA
05/2013
1ChitosanIBA
05/2013
1Interferon-gamma (Interferon, gamma)IBA
03/2013
1Galectin 3 (LGALS3)IBA
03/2013
1LectinsIBA
03/2013
1cyclic diadenosine phosphateIBA
12/2012
1Small Interfering RNA (siRNA)IBA
12/2012
1Transcription Factors (Transcription Factor)IBA
12/2012
1bis(3',5')-cyclic diguanylic acidIBA
12/2012
1B-Form DNA (B-DNA)IBA
11/2012
1Imatinib Mesylate (Gleevec)FDA Link
10/2012
1Pharmaceutical PreparationsIBA
10/2012
1Protein Isoforms (Isoforms)IBA
08/2012
1Toll-Like Receptor 1IBA
03/2012
1LipopeptidesIBA
03/2012
1NucleotidesIBA
03/2012
1Acetylmuramyl-Alanyl-IsoglutamineIBA
03/2012
1Mannose ReceptorIBA
10/2011
1lipomannanIBA
10/2011
1retapamulinFDA Link
04/2011

Therapy/Procedure

10Therapeutics
01/2022 - 08/2005
1Aftercare (After-Treatment)
11/2019
1Immunotherapy
12/2015
1Drug Therapy (Chemotherapy)
08/2014